LION BIOTECHNOLOGIES, INC. PROXY STATEMENT

Company

IOVANCE BIOTHERAPEUTICS, INC.

Filed

September 23, 2014

Period of Report

November 3, 2014

Accession Number

0001513160-14-000049

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →